CTCReveal

About Danner Laboratory

Danner Laboratory is a private, revenue-generating diagnostics company with roots dating to 1991, now operating from San Francisco with a focus on preventive oncology. Its core offering is the CTCReveal liquid biopsy test, which uses validated reagents and AI-powered imaging (CellSPOT-300) to detect circulating tumor cells from a simple blood draw. The company targets the growing liquid biopsy market by providing a minimally invasive alternative to tissue biopsies for cancer management, aiming to enable early detection and improve patient outcomes. It positions itself as a clinical laboratory service provider trusted by physicians for over two decades.

Therapeutic Areas